Home
>
National Drug Code (NDC)
>
DOXOrubicin Hydrochloride
DOXOrubicin Hydrochloride - 62756-827-40 - (DOXOrubicin Hydrochloride)
Drug Information of DOXOrubicin Hydrochloride
| Product NDC: | 62756-827 |
| Proprietary Name: | DOXOrubicin Hydrochloride |
| Non Proprietary Name: | DOXOrubicin Hydrochloride |
| Active Ingredient(s): | 2 mg/mL & nbsp; DOXOrubicin Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of DOXOrubicin Hydrochloride
| Product NDC: | 62756-827 |
| Labeler Name: | Sun Pharmaceutical Industries Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091418 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120220 |
Package Information of DOXOrubicin Hydrochloride
| Package NDC: | 62756-827-40 |
| Package Description: | 1 VIAL, MULTI-DOSE in 1 BOX (62756-827-40) > 100 mL in 1 VIAL, MULTI-DOSE |
NDC Information of DOXOrubicin Hydrochloride
| NDC Code | 62756-827-40 |
| Proprietary Name | DOXOrubicin Hydrochloride |
| Package Description | 1 VIAL, MULTI-DOSE in 1 BOX (62756-827-40) > 100 mL in 1 VIAL, MULTI-DOSE |
| Product NDC | 62756-827 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | DOXOrubicin Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120220 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharmaceutical Industries Limited |
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
